European Society of Intensive Care Medicine 2018 in Paris, France

Cerenion Oy and Bittium Oyj will take part at the 31st annual congress of the European Society of Intensive Care Medicine (ESICM) in Paris, France from the 21st to the 24th of October 2018.
The annual congress holds a premier spot as the meeting place for medical professionals and industry in the field of intensive care medicine. The congress, consisting of a strong scientific program, a well-attended industry exhibition and a range of training sessions is expected to again attract an audience of over 6,000 physicians, anaesthetists, trainees and nursing and allied health professionals from around 100 countries all across the world.
Cerenion Oy and Bittium Oyj will present their joint work in bringing next-generation brain monitoring technology to intensive care. Come by stand 3.27 (level 3 – block 7) to learn more about the combination of Cerenion's C-Trend™ technology (pat. pend.) and Bittium's BrainStatus platform.
Cerenion Oy will be represented by Dr. Timo Koskela, Co-founder and CEO, at the event. If you would like to arrange a meeting with us at the event please contact Timo directly. In addition, our Chief Medical Officer, Dr. Jukka Kortelainen will be speaking as part of the scientific program of the congress.
Meet us at stand 3.27 (level 3 – block 7). See you there!

Find out more

Timo Koskela
PhD (Eng.), MSc (Econ.&Bus.Adm)
CFO, Co-founder
Visit us
Contact us
Cerenion Oy has received support from the European Regional Development Fund of the European Union.
Cerenion Oy
Elektroniikkatie 3
90590 Oulu
Cerenion Oy
Kyllikinportti 2
00240 Helsinki
Call us: +358 50 447 4909
E-mail us:
This website and all of the content therein is for reference purposes only and is not intended to substitute for advice from a licensed healthcare professional. Not available in the United States. Cerenion™, Cerenion C-Trend™, C-Trend™, "The next-generation brain monitoring company"™ and "The pulse of the brain"™ are registered trademarks and/or trademarks of Cerenion Oy. Cerenion C-Trend™ is intended for use by qualified medical practitioners who will exercise professional judgment in its use. Cerenion technology is protected by Intellectual Property Rights. Patents pending worldwide. All rights reserved. © Cerenion Oy 2020.
Powered by:MetaVisual CMSMobile versionDesktop versionLog in© 2017 - 2023 Cerenion Oy